ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer
Yuzhen Zhou(Dana-Farber Cancer Institute), Kent W. Mouw(Massachusetts General Hospital)
Cited by 23
Related Papers
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
|Journal of Clinical Investigation|2018|209
<i>CDKN2A</i> Alterations and Response to Immunotherapy in Solid Tumors
|Clinical Cancer Research|2021|129
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
|Cancer Cell|2022|117
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
|Journal of Clinical Investigation|2018|53
APOBEC3A-Induced DNA Damage Drives Polymerase θ Dependency and Synthetic Lethality in Cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1